Liver Diseases  >>  Licartin (Iodine-131-labeled metuximab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Licartin (Iodine-131-labeled metuximab) / Chinese Government
NCT00819650: A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection

Completed
2
200
RoW
Licartin (generic name,[131I]metuximab injection), no adjuvant therapy after liver resection
Eastern Hepatobiliary Surgery Hospital
Hepatocellular Carcinoma
12/09
12/10

Download Options